Suppr超能文献

非甾体抗炎药的使用与帕金森病发病无关:一项挪威处方数据库研究。

NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study.

机构信息

Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.

Department of Clinical Medicine, University of Bergen, Bergen, Norway.

出版信息

PLoS One. 2021 Sep 7;16(9):e0256602. doi: 10.1371/journal.pone.0256602. eCollection 2021.

Abstract

OBJECTIVE

Whether use of nonsteroidal anti-inflammatory drugs (NSAIDs) reduce the risk of incident Parkinson's disease (PD) remains unresolved. Here, we employed the Norwegian Prescription Database to examine whether NSAID use is associated with a lower incidence of PD.

METHODS

We compared the incidence of PD among users of NSAIDs in a population-based retrospective study using the Norwegian Prescription Database from 2004 to 2017. In total 7580 PD patients were identified using dopaminergic therapy over time as proxy for PD diagnosis. Analyses were performed with minimum 90 and 365 defined daily dose (DDD) NSAID exposure, respectively. Time-dependent Cox regression model and a binary logistic regression analysis with a 5-year lag until PD diagnosis were performed for all NSAIDs.

RESULTS

There was overall no decrease in incidence of PD among NSAID users compared to controls. Using a minimum of 90 or 365 DDD threshold of exposure produced similar results. Analysis of individual NSAIDs did not show difference in PD incidence compared to controls Age-specific incidence rates of PD were comparable to reported age-specific incidence rates in previous studies.

INTERPRETATION

Our findings provide no evidence that cumulative high exposure to NSAIDs affects the risk of developing PD.

摘要

目的

非甾体抗炎药(NSAIDs)的使用是否降低帕金森病(PD)的发病风险仍未解决。在这里,我们利用挪威处方数据库来研究 NSAID 的使用是否与较低的 PD 发病率相关。

方法

我们在一项基于人群的回顾性研究中,利用挪威处方数据库(2004 年至 2017 年),比较了 NSAID 使用者的 PD 发病率。共通过多巴胺能治疗的时间来确定 7580 名 PD 患者作为 PD 诊断的替代指标。使用最小 90 和 365 日定义剂量(DDD)的 NSAID 暴露分别进行了时间依赖性 Cox 回归模型和 5 年滞后至 PD 诊断的二元逻辑回归分析。

结果

与对照组相比,NSAID 使用者的 PD 发病率总体上没有降低。使用最小 90 或 365 DDD 暴露阈值产生了类似的结果。与对照组相比,对个别 NSAID 的分析并未显示 PD 发病率的差异。与之前研究报告的年龄特异性 PD 发病率相比,特定年龄的 PD 发病率相当。

解释

我们的研究结果没有提供累积高剂量 NSAID 暴露会影响 PD 发病风险的证据。

相似文献

1
NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study.
PLoS One. 2021 Sep 7;16(9):e0256602. doi: 10.1371/journal.pone.0256602. eCollection 2021.
2
NSAID use and risk of Parkinson disease: a population-based case-control study.
Eur J Neurol. 2011 Nov;18(11):1336-42. doi: 10.1111/j.1468-1331.2011.03399.x. Epub 2011 Apr 4.
3
NSAID use and the risk of Parkinson's disease.
Curr Drug Saf. 2006 Aug;1(3):223-5. doi: 10.2174/157488606777934404.
4
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
Neuroepidemiology. 2011;36(3):155-61. doi: 10.1159/000325653. Epub 2011 Apr 20.
5
Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study.
J Clin Neurosci. 2008 May;15(5):576-7. doi: 10.1016/j.jocn.2007.02.095. Epub 2008 Mar 14.
7
Glitazone use associated with reduced risk of Parkinson's disease.
Mov Disord. 2017 Nov;32(11):1594-1599. doi: 10.1002/mds.27128. Epub 2017 Sep 1.
8
Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease.
Neurology. 2006 Apr 11;66(7):1097-9. doi: 10.1212/01.wnl.0000204446.82823.28.
10

引用本文的文献

1
Association of Medication Use and 8-Year Mortality Risk in Patients With Parkinson Disease: Drug-Wide Trial Emulation.
Neurology. 2025 Aug 12;105(3):e213783. doi: 10.1212/WNL.0000000000213783. Epub 2025 Jul 11.
2
Epidemiology of Parkinson's Disease: An Update.
Curr Neurol Neurosci Rep. 2024 Jun;24(6):163-179. doi: 10.1007/s11910-024-01339-w. Epub 2024 Apr 20.
3
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond.
Curr Neuropharmacol. 2024;22(6):1080-1109. doi: 10.2174/1570159X22666231017141636.
4
5
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects.
Inflammopharmacology. 2023 Apr;31(2):673-688. doi: 10.1007/s10787-023-01192-2. Epub 2023 Mar 24.
6
Dopamine, Immunity, and Disease.
Pharmacol Rev. 2023 Jan;75(1):62-158. doi: 10.1124/pharmrev.122.000618. Epub 2022 Dec 8.

本文引用的文献

1
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
Brain. 2020 Oct 1;143(10):3067-3076. doi: 10.1093/brain/awaa262.
2
Non-steroidal anti-inflammatory drugs and risk of Parkinson's disease in the elderly population: a meta-analysis.
Eur J Clin Pharmacol. 2019 Jan;75(1):99-108. doi: 10.1007/s00228-018-2561-y. Epub 2018 Oct 2.
3
Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease: A dose-response meta-analysis.
Medicine (Baltimore). 2018 Sep;97(37):e12172. doi: 10.1097/MD.0000000000012172.
5
Glitazone use associated with reduced risk of Parkinson's disease.
Mov Disord. 2017 Nov;32(11):1594-1599. doi: 10.1002/mds.27128. Epub 2017 Sep 1.
6
Parkinson disease.
Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13.
7
Simvastatin is associated with decreased risk of Parkinson disease.
Ann Neurol. 2017 Feb;81(2):329-330. doi: 10.1002/ana.24857.
8
Reduced Risk of Parkinson Disease in Patients With Rheumatoid Arthritis: A Nationwide Population-Based Study.
Mayo Clin Proc. 2016 Oct;91(10):1346-1353. doi: 10.1016/j.mayocp.2016.06.023.
9
Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.
Am J Epidemiol. 2016 Aug 15;184(4):325-35. doi: 10.1093/aje/kwv445. Epub 2016 Jul 25.
10
Time Trends in the Incidence of Parkinson Disease.
JAMA Neurol. 2016 Aug 1;73(8):981-9. doi: 10.1001/jamaneurol.2016.0947.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验